BRAF and colorectal carcinoma: While a review regarding multiple CRC biomarkers, including RAS and BRAF status, showed a strong agreement between the primary CRC and its metastatic site(s) [27], therapeutic pressure induced by chemotherapy and/or targeted treatment may alter the status post-treatment.